… Here, a trader who bought shares in the two pharmaceutical companies at issue would either be a victim or not a victim based on who the counter-party was on particular days – in faceless, electronic transactions. If they were lucky enough to have been matched with CR Intrinsic, they win a piece of the fair fund. If not, they lose.
